Figure 8.

Kaplan–Meier survival analysis. Patients with a higher risk score demonstrated a worse prognosis than those with a low risk score in the training cohort for OS of TCBM patients (A), for CSS of TCBM patients (C), and validation cohort for OS of TCBM patients (B), for CSS of TCBM patients (D).